barbigerone has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Li, X; Peng, A; Wang, X; Ye, H | 1 |
1 other study(ies) available for barbigerone and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Human Umbilical Vein Endothelial Cells; Humans; Isoflavones; Laminin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Proteoglycans; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish | 2012 |